Praxis Precision Medicines (PRAX) Total Current Liabilities: 2022-2025
Historic Total Current Liabilities for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $52.9 million.
- Praxis Precision Medicines' Total Current Liabilities rose 60.93% to $52.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.9 million, marking a year-over-year increase of 60.93%. This contributed to the annual value of $37.5 million for FY2024, which is 138.43% up from last year.
- Praxis Precision Medicines' Total Current Liabilities amounted to $52.9 million in Q3 2025, which was up 8.79% from $48.6 million recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Total Current Liabilities ranged from a high of $52.9 million in Q3 2025 and a low of $15.7 million during Q4 2023.
- Its 3-year average for Total Current Liabilities is $30.7 million, with a median of $29.9 million in 2023.
- As far as peak fluctuations go, Praxis Precision Medicines' Total Current Liabilities tumbled by 54.14% in 2023, and later spiked by 138.43% in 2024.
- Praxis Precision Medicines' Total Current Liabilities (Quarterly) stood at $34.3 million in 2022, then tumbled by 54.14% to $15.7 million in 2023, then soared by 138.43% to $37.5 million in 2024, then skyrocketed by 60.93% to $52.9 million in 2025.
- Its last three reported values are $52.9 million in Q3 2025, $48.6 million for Q2 2025, and $39.5 million during Q1 2025.